Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer

Cancer Science

Volumn 96, Issue 6, 2005, Pages 323-332

  Yanagihara, Kazuyoshi ^a   Takigahira, Misato ^a   Tanaka, Hiromi ^a   Komatsu, Teruo ^a   Fukumoto, Hisao ^b   Koizumi, Fumiaki ^b   Nishio, Kazuto ^a   Ochiya, Takahiro ^a   Ino, Yoshinori ^a   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; GEMCITABINE; IRINOTECAN; PROTEINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; CELL ISOLATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG SYNTHESIS; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; GREATER OMENTUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENTERY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOPHYSIOLOGY; PERITONEUM; PERITONEUM METASTASIS; PRIORITY JOURNAL; REPRODUCIBILITY; STOMACH CARCINOMA; SURVIVAL TIME;

ADENOCARCINOMA, SCIRRHOUS; ANIMALS; ANTINEOPLASTIC AGENTS; ASCITES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL; TUMOR CELLS, CULTURED;

EID: 22444441279     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00054.x     Document Type: Article

References (43)

1. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. [i#Gastric Cancer#1i] 1998; [b#1#1b]: 10-24.
2. Tahara E. Endocrine tumors of the gastrointestinal tract: classification, function and biological behavior. In: Watanabe S, Wolff M, Sommers SC, eds. [i#Digestive Disease Pathology#1i]. Philadelphia: Field andWood, 1988; 121-47.
3. Fenoglio-preier C, Carneiro F, Correa P [i#et al.#1i] Gastric carcinoma. In: Hamilton SR, Aaltonen LA, eds. [i#World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System#1i]. Lyon: IARC Press, 2000; 37-52.
4. Maruyama K. Results of surgery correlated with staging. In: Preece PE, Cuschieri A, Wellwood JM, eds. [i#Cancer of the Stomach#1i]. Orlando: Grune and Stratton, 1986; 145-63.
5. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Nose Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. [i#Surg Oncol#1i] 1992; [b#1#1b]: 341-6.
6. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. [i#Clin Exp Metastasis#1i] 1996; [b#14#1b]: 43-54.
7. Fujita S, Suzuki H, Kinoshita M, Hirohashi S. Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin β1 subunit antibody. [i#Jpn J Cancer Res#1i] 1992; [b#83#1b]: 1317-26.
8. Ishii Y, Ochiai A, Yamada T [i#et al.#1i] Integrin α6β4 as a suppressor and a predictive marker for peritoneal dissemination in human gastric cancer. [i#Gastroenterology#1i] 2000; [b#118#1b]: 497-506.
9. Kotanagi H, Saito Y, Shinozawa N, Koyama K. Establishment of a human cancer cell line with high potential for peritoneal dissemination. [i#J Gastroenterol#1i] 1995; [b#30#1b]: 437-8.
10. Kaneko K, Yano M, Tsujinaka T [i#et al.#1i] Establishment of a visible peritoneal micrometastatic model from a gastric adenocarcinoma cell line by green fluorescent protein. [i#Int J Oncol#1i] 2000; [b#16#1b]: 893-8.
11. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. [i#Cancer Res#1i] 1991; [b#51#1b]: 381-6.
12. Yanagihara K, Kamada N, Tsumuraya M, Amano F. Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. [i#Int J Cancer#1i] 1993; [b#54#1b]: 200-7.
13. Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. [i#Cancer Res#1i] 1993; [b#53#1b]: 5815-21.
14. Yanagihara K, Tanaka H, Takigahira M [i#et al.#1i] Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. [i#Cancer Sci#1i] 2004; [b#95#1b]: 575-82.
15. Lou L, Salunga RC, Guo H [i#et al.#1i] Gene expression profiles of laser-captured adjacent neuronal subtypes. [i#Nat Med#1i] 1999; [b#5#1b]: 117-22.
16. Hughes TR, Mao M, Jones AR [i#et al.#1i] Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. [i#Nat Biotechnol#1i] 2001; [b#19#1b]: 342-7.
17. Kanzawa F, Saijo N. [i#In vitro#1i] interaction between gemcitabine and other anticancer drugs using a novel three-dimensional model. [i#Semin Oncol#1i] 1997; [b#24#1b]: S7-8-S7-16.
18. Saijo N. Preclinical and clinical trials of topoisomerase inhibitors. [i#Ann N Y Acad Sci#1i] 2000; [b#922#1b]: 92-9.
19. Fidler IJ. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. [i#Cancer Metast Rev#1i] 1986; [b#5#1b]: 29-49.
20. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. [i#Nat Genet#1i] 2003; [b#33#1b]: 49-54.
21. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. [i#Int Rev Cytol#1i] 2001; [b#204#1b]: 49-95.
22. Yasui W, One N, Ito R, Kuraoka K, Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. [i#Cancer Sci#1i] 2004; [b#95#1b]: 385-92.
23. Hippo Y, Yashiro M, Ishii M [i#et al.#1i] Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. [i#Cancer Res#1i] 2001; [b#61#1b]: 889-95.
24. Hippo Y, Taniguchi H, Tsutsumi S [i#et al.#1i] Global gene expression analysis of gastric cancer by oligonucleotide microarrays. [i#Cancer Res#1i] 2002; [b#62#1b]: 233-40.
25. Hasegawa S, Furukawa Y, Li M [i#et al.#1i] Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23 040 genes. [i#Cancer Res#1i] 2002; [b#62#1b]: 7012-7.
26. Weiss MM, Kuipers EJ, Postma C [i#et al.#1i] Genomic profiling of gastric cancer predicts lymph node status and survival. [i#Oncogene#1i] 2003; [b#22#1b]: 1872-9.
27. Inoue T, Yashiro M, Nishimura S [i#et al.#1i] Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. [i#Int J Mol Med#1i] 1999; [b#4#1b]: 73-7.
28. Sakurai Y, Otani Y, Kameyama K [i#et al.#1i] Therole of stromal cells in the expression of interstitial collagenase (matrix metalloproteinase-1) in the invasion of gastric cancer. [i#J Surg Oncol#1i] 1997; [b#66#1b]: 168-72.
29. Dohchin A, Suzuki JI, Seki H, Masutani M, Shiroto H, Kawakami Y. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. [i#Cancer#1i] 2000; [b#89#1b]: 482-7.
30. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. [i#Am J Pathol#1i] 1998; [b#153#1b]: 333-9.
31. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive; properties after the loss of uvomorulin-mediated cell-cell adhesion. [i#J Cell Biol#1i] 1989; [b#108#1b]: 2435-47.
32. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulated E-cadherin and promotes metastasis. [i#Proc Natl Acad Sci USA#1i] 2002; [b#99#1b]: 365-70.
33. Yokozaki H, Ito R, Nakayama H, Kuniyasu H, Taniyama K, Tahara E. Expression of CD44 abnormal transcripts in human gastric carcinomas. [i#Cancer Lett#1i] 1994; [b#83#1b]: 229-34.
34. Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M. CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. [i#Jpn J Cancer Res#1i] 1996; [b#87#1b]: 1235-44.
35. Tsugawa K, Yonemura Y, Hirono Y [i#et al.#1i] Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features. [i#Oncology#1i] 1998; [b#55#1b]: 475-81.
36. Kunuyasu H, Yoshida K, Yokozaki H [i#et al.#1i] Expression of cript, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas. [i#Jpn J Cancer Res#1i] 1991; [b#82#1b]: 969-73.
37. Kunuyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. [i#Int J Cancer#1i] 1993; [b#55#1b]: 72-5.
38. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. [i#Clin Cancer Res#1i] 1986; [b#2#1b]: 1679-84.
39. Huang SP, Wu MS, Wang HP, Yang PS, Kuo ML, Lin JT. Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma. [i#J Gastroenterol Hepatol#1i] 2002; [b#17#1b]: 1165-9.
40. Kitadai Y, Haruma K, Sumii K [i#et al.#1i] Regulation of angiogenesis in human gastric carcinomas by interleukin-8. [i#Am J Pathol#1i] 1998; [b#152#1b]: 93-100.
41. Ueki T, Koji T, Tamiya S, Nakane PK, Tsuneyoshi M. Expression of basic fibroblast growth factor and fibroblast growth factor in advanced gastric carcinoma. [i#J Pathol#1i] 1995; [b#177#1b]: 353-61.
42. Nakayama H, Yasui W, Yokozaki H, Tahara E. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. [i#Jpn J Cancer Res#1i] 1993; [b#84#1b]: 184-90.
43. Ijichi H, Ikenoue T, Kato N [i#et al.#1i] Systemic analysis of the TGF-beta-smad signaling pathway in gastrointestinal cancer cells. [i#Biochem Biophys Res Commun#1i] 2001; [b#289#1b]: 350-7.